Oncotarget

Research Papers:

Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy

Robin M. Hallett _, Cheng Huang, Ali Motazedian, Stefanie Auf der Mauer, Gregory R. Pond, John A. Hassell, Robert E. Nordon and Jonathan S. Draper

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:7040-7052. https://doi.org/10.18632/oncotarget.3140

Metrics: PDF 1048 views  |   HTML 1688 views  |   ?  


Abstract

Robin M. Hallett3, Cheng Huang1,3, Ali Motazedian1,3,6, Stefanie Auf der Mauer4, Gregory R. Pond5, John A. Hassell2,3, Robert E. Nordon4, Jonathan S. Draper1,2,3

1McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada

2Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada

3Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8N 3Z5, Canada

4Graduate School of Biomedical Engineering, University of New South Wales, Sydney 2052, Australia

5Department of Oncology, McMaster University, Hamilton, ON L8N 3Z5, Canada

6Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria 3052, Australia

Correspondence to:

Jonathan S. Draper, e-mail: draperj@mcmaster.ca

Keywords: Breast cancer, chemotherapy, cell cycle, p53

Received: January 05, 2015     Accepted: January 11, 2015     Published: February 07, 2015

ABSTRACT

Chemotherapy fails to provide durable cure for the majority of cancer patients. To identify mechanisms associated with chemotherapy resistance, we identified genes differentially expressed before and after chemotherapeutic treatment of breast cancer patients. Treatment response resulted in either increased or decreased cell cycle gene expression. Tumors in which cell cycle gene expression was increased by chemotherapy were likely to be chemotherapy sensitive, whereas tumors in which cell cycle gene transcripts were decreased by chemotherapy were resistant to these agents. A gene expression signature that predicted these changes proved to be a robust and novel index that predicted the response of patients with breast, ovarian, and colon tumors to chemotherapy. Investigations in tumor cell lines supported these findings, and linked treatment induced cell cycle changes with p53 signaling and G1/G0 arrest. Hence, chemotherapy resistance, which can be predicted based on dynamics in cell cycle gene expression, is associated with TP53 integrity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3140